Oxurion NV
BioTech/Drugs - Iselin, NJ, US
Oxurion NV Employees
Joke Debruyn
Senior Clinical Operations Scientist (Medical Writing and Clinical Operations)
Hanne Callewaert
Global Head of Regulatory Affairs, Business Development - Out-licensing and Alliance Management
Oxurion NV Details
Oxurion (Euronext Brussels: OXUR) is a biopharmaceutical company developing next generation standard of care ophthalmic therapies, which are designed to better preserve vision in patients with retinal vascular disorders including diabetic macular edema (DME), the leading cause of vision loss in diabetic patients worldwide as well as other conditions, including wet age-related macular degeneration (AMD) and retinal vein occlusion (RVO). Oxurion is aiming to build the leading global franchise in the treatment of retinal vascular disorders based on the successful development of its two novel therapeutics:• THR-149, a plasma kallikrein inhibitor being developed as a potential new standard of care for the 40% of DME patients who respond suboptimally to anti-VEGF therapy. THR-149 has shown positive topline Phase 1 results for the treatment of DME. The company is currently conducting a Phase 2 clinical trial evaluating multiple injections of THR-149 in DME patients who previously responded suboptimally to anti-VEGF therapy. • THR-687 is a pan-RGD integrin antagonist that is initially being developed as a potential first line therapy for DME patients. Positive topline results in a Phase 1 clinical study assessing THR-687 as a treatment for DME were announced in 2020. THR-687 is expected to enter a Phase 2 clinical trial in mid-2021. THR-687, also has the potential to deliver improved treatment outcomes for patients with wet AMD and RVO.Oxurion is headquartered in Leuven, Belgium, and is listed on the Euronext Brussels exchange under the symbol OXUR.
Oxurion NV Technologies
Frameworks and Programming Languages
ASP.NET
Email Providers
Outlook
Content Delivery Networks
Amazon CloudFront
Load Balancers
Amazon Elastic Load Balancer
Hosting
Amazon AWS
Online Video Platforms
YouTube